EsoBiotec

Mont-saint-guibert, Belgium

EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

$2.2M raised

Dec 2023

Series A

Top Investors

Thuja CapitalInvivo Capital PartnersS.R.I.W.UCB VenturesSambrinvest

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EsoBiotec raised?

EsoBiotec has raised $2.2M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are EsoBiotec's investors?

EsoBiotec's investors include Thuja Capital, Invivo Capital Partners, S.R.I.W., UCB Ventures, Sambrinvest.

Where is EsoBiotec headquartered?

EsoBiotec is headquartered in Mont-saint-guibert, Belgium.

What does EsoBiotec do?

EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

What stage is EsoBiotec at?

EsoBiotec is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2023.

MLA

"EsoBiotec — Funding & Investors." VCBacked, December 12, 2023, https://www.vcbacked.co/company/esobiotec. Accessed June 4, 2026.

APA

VCBacked. (2023). EsoBiotec — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/esobiotec

Wikipedia (cite web)

{{cite web |title=EsoBiotec — Funding & Investors |url=https://www.vcbacked.co/company/esobiotec |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2023.